Seqster Streamlines Regulatory Submissions & Health Data Sharing with FDA 21 CFR Part 11 Compliance

SAN DIEGO, Sept. 3, 2020 /PRNewswire/ — Seqster, the award-winning SaaS-based healthcare technology company enabling patient-centric interoperability, today announced that it reached a significant milestone with the receipt of its FDA 21 CFR PART 11 Compliance letter. This regulatory requirement is for any company that supports pharmaceutical partners in making electronic submissions to the FDA with patient Electronic Health Record (EHR) data. This is another market first for Seqster and accelerates the adoption of Seqster’s interoperability technology for enhancing clinical trials, patient engagement, and outcomes.

“Achieving FDA compliance is another industry first for Seqster and exemplifies our commitment to our pharma clients by automating the delivery of Real-World Data in real-time, bringing life-saving medicines to the market faster,” stated Ardy Arianpour, Seqster’s CEO and co-founder. “Our platform ensures patient data authenticity, integrity, and confidentiality during the submission of electronic records. Now with our FDA compliance letter, any pharmaceutical company that needs to make a regulatory submission with RWD can do so by plugging Seqster into their clinical trials.”

Seqster provides a suite of applications to pharma partners providing clinical trial patients a secure platform to consent and share their data with investigators and study personnel in real-time, creating a longitudinal health record. 

With Seqster’s FDA 21 CFR Part 11 Compliance, pharmaceutical companies can now achieve:

1)    FDA submissions with Real-World Data (RWD)

2)    Clinical trials with data meeting the highest levels of data provenance, integrity, and accuracy validation

3)    Enhanced patient compliance and outcomes while fulfilling the requirements on maintaining records and submitting information to FDA

ABOUT SEQSTER

Seqster is a SaaS-based healthcare technology company that enables organizations to drive efficient healthcare via comprehensive medical records (EHR), individual genomic profiles (DNA), and personal health device data. For the first time, users create their own matched, longitudinal health data profile across all of their US-based healthcare data sources through person-centric interoperability. The company serves healthcare enterprises such as pharmaceutical companies, payers, life insurance, and providers.

The platform is both FDA 21 CFR PART 11 & CMS-ONC 21st Century Cures Act Compliant. Seqster is hosted on HIPAA-compliant and HITRUST certified servers. It connects users to more than 3,000 hospitals and health systems and over 150,000 doctor offices and medical clinics nationwide. Seqster is privately held and headquartered in San Diego.

If you are interested in partnering with Seqster, please contact: bd@seqster.com
Learn more about our technology at seqster.com, follow us @Seqster

View original content to download multimedia:http://www.prnewswire.com/news-releases/seqster-streamlines-regulatory-submissions–health-data-sharing-with-fda-21-cfr-part-11-compliance-301123591.html

SOURCE Seqster